10x Genomics, Inc. (TXG) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for 10x Genomics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -46.73x | -9.47x | -25.70x | -24.99x | -282.32x | -26.39x |
| P/B Ratio | 2.56x | 2.44x | 8.85x | 5.15x | 20.11x | 19.38x |
| P/S Ratio | 3.17x | 2.83x | 10.60x | 8.03x | 33.51x | 47.93x |
| Profitability | ||||||
| Gross Margin | 69.1% | 67.9% | 66.2% | 76.7% | 84.9% | 80.4% |
| Operating Margin | -17.2% | -31.9% | -42.9% | -32.5% | -10.8% | -28.6% |
| Net Margin | -6.8% | -29.9% | -41.2% | -32.1% | -11.9% | -181.6% |
| EBITDA Margin | -17.2% | -21.9% | -33.2% | -24.9% | -5.0% | -171.9% |
| Liquidity | ||||||
| Current Ratio | 4.46x | 4.97x | 4.69x | 4.85x | 6.77x | 6.56x |
| Quick Ratio | 4.09x | 4.26x | 4.11x | 4.23x | 6.23x | 6.30x |
| Leverage | ||||||
| Debt/Equity | 0.20x | 0.12x | 0.13x | 0.12x | 0.10x | 0.09x |
YoY = year-over-year change. Source: FMP..